IDEX Biometrics (IDEX)

[TekBot]

Disclosure of voting rights in IDEX Biometrics - chair Morten Opstad - 13 May 2020

At the close of business on 13 May 2020, Morten Opstad, chair of the board of
IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose
of the extraordinary general meeting on 15 May 2020:
…

Vis børsmeldingen

Total 178,118,810 shares or 24.81% of the share capital and votes, consisting of
the following:
Proxy to represent and vote for 111,730,411 shares or 15.56% of the share
capital, including shares held by Mr Opstad and close relations.
Proxy with voting instructions for 66,388,399 shares or 9.25% of the share
capital.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

Supplemental proposal to IDEX Biometrics’s 2020 annual general meeting

The board of directors of IDEX Biometrics ASA proposes the following supplement
to agenda item 5 - 2020 Subscription Rights Incentive Plan at the 2020 annual
general meeting on Friday 15 May 2020.
…

Vis børsmeldingen

Background:
As of 31 March 2020 the Company had 57,095,893 subscription rights outstanding
under Subscription Rights-based incentive programmes 2016 to 2018, at weighted
averege exercise price of NOK 5.40 per share (“Existing Subscription Rights”).
As the share price for a long time has been significantly lower, these
subscription rights have no intrinsic value. The Board wishes subscription
rights to have a real potential value and thus represent an actual incentive for
the employees. The Board therefore proposes that the Company may offer employees
and individual contractors who hold Existing Subscription Rights (“Existing
Subscription Rights Holders”) to receive new subscription rights under the 2020
Subscription Rights Incentive Plan against waiver of their Existing Subscription
Rights. Because the vesting period re-starts, the Board proposes a three-year
vesting period, at 1/3 per year.

Supplement to the original proposed resolution, to be inserted as a new
fourteenth paragraph in the resolution:
“Subscription rights that are issued against waiver of Existing Subscription
Rights (“Replacement Subscription Rights”) must be issued latest 31 August
2020. The vesting schedule for Replacement Subscription Rights shall be 1/3 per
year where the first tranche vests on 15 April 2021. As consideration for the
shares to be issued in the Company upon exercise of the Replacement Subscription
Rights, the holders of the subscription rights shall pay to the Company of
minimum NOK 1.71 per share, which was the closing price of the Company’s share
on Oslo Børs on 11 May 2020. For the avoidance of doubt, the Board may elect to
offer fewer, bot not more Replacement Subscription Rights than the number of
Existing Subscription Rights each holder owns. The Board can resolve further
rules and procedures for offer and acceptance of grant of Replacement
Subscription Rights against waiver of Existing Subscription rights. Other than
the foregoing, the terms and conditions in this resolution apply correspondingly
to the Replacement Subscription Rights.”

The board acknowledges that the proposal on agenda item 5 means that the
shareholders’ preferential rights to subscribe for subscription rights according
to the PLCA section 11-13 is deviated from. The board has considered the
proposal in view of the STA section 5-14 and holds the view that the
subscription rights holders may be subject to differential terms, and notes that
the total number of subscription rights outstanding at any time is limited to
10% of the registered number of shares in the Company., and that the
subscription rights are issued to employees and individual contractors with the
purpose and expectation that such share-based incentives will represent a long-
term benefit for the Company and its shareholders.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com (mailto:marianne.boe@idexbiometrics.com)
Tel: + 47 918 00186
Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
(mailto:derek.dantilio@idexbiometrics.com) Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com) and follow on Twitter @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

Tilleggsforslag til IDEX Biometrics’ generalforsamling 2020

Styret i IDEX Biometrics ASA foreslår følgende tillegg til sakslisten punkt 5 -
Tegningsrettsbasert incentivplan 2020 på ordinær generalforsamling fredag 15.
mai 2020.
…

Vis børsmeldingen

Bakgrunn:
Selskapet hadde per 31. mars 2020 utestående 57 095 893 tegningsretter under
tegningsretts-baserte insentivprogrammer fra 2016 til 2018 med vektet
utøvelsespris på 5,40 NOK per aksje («Eksisterende Tegningsretter»). Ettersom
kursen på selskapets aksjer lenge har vært vesentlig lavere, er disse
tegningsretter uten reell verdi. Styret ønsker at tegningsrettene skal ha en
reell potensiell verdi og dermed representere et faktisk insentiv for de
ansatte. Styret foreslår derfor at Selskapet kan tilby ansatte og individuelle
innleide personer som innehar Eksisterende Tegningsretter («Eksisterende
Tegningsrettsinnehavere») å motta nye tegningsretter under Tegningsrettsbasert
insentivprogram 2020 mot å frafalle sine Eksisterende Tegningsretter. Fordi
opptjeningstiden begynner på ny, foreslås opptjeningstid på tre år, med 1/3
årlig.

Tillegg til det opprinnelige vedtaksforslaget, som settes inn som et nytt,
fjortende avsnitt i vedtaket:
«Tegningsretter som utstedes mot at Eksisterende Tegningsretter frafalles
(«Fornyede Tegningsretter»), må tildeles senest 31. august 2020. Fornyede
Tegningsretter skal ha en innløsningsplan med 1/3 hvert år der første transje
opptjenes 15. april 2021. Som vederlag for aksjene som skal utstedes i Selskapet
ved utøvelse av Fornyede Tegningsretter skal innehaverne betale minimum 1,71 NOK
per aksje, som var sluttkurs på Selskapets aksje på Oslo Børs den 11. mai 2020.
For å unngå tvil stadfestes at styret kan velge å tilby færre, men ikke flere,
Fornyede Tegningsretter enn det antall Eksisterende Tegningsretter hver enkelt
innehaver eier. Styret kan fastsette nærmere regler og prosedyrer for tilbud om
og aksept av tildeling av Fornyede Tegningsretter mot frafall av Eksisterende
Tegningsretter. For øvrig gjelder bestemmelsene i dette vedtaket tilsvarende for
Fornyede Tegningsretter. "

Styret anser at forslaget i dette punkt 5 på sakslisten innebærer at
aksjonærenes fortrinnsrett til å tegne tegningsretter iht. allmennaksjelovens
paragraf 11-13 fravikes. Styret har vurdert forslaget opp mot
verdipapirhandellovens paragraf 5-14 og er av den oppfatning at
tegningsrettsinnehaverne kan undergis ulik behandling, og bemerker at det totalt
antall utestående tegningsretter på ethvert tidspunkt er begrenset til 10% av
det registrerte antall aksjer i Selskapet, samt at tegningsrettene tildeles
ansatte og individuelle innleide personer med det formål og forventning at slike
aksjebaserte insentiver vil medføre langsiktige fordeler for både Selskapet og
dets aksjonærer.

For ytterligere informasjon, kontakt:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com (mailto:marianne.boe@idexbiometrics.com)
Tel: + 47 918 00186
Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
(mailto:derek.dantilio@idexbiometrics.com) Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com) and follow on Twitter @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

IDEX Biometrics ASA: Nomination committee’s propsal to annual general meeting - Valgkomiteens innstilling til ordinær generalforsamling

Please refer to enclosed file:

AGM 20200515 Nomination Committe ENG ES (http://ml-
…

Vis børsmeldingen

eu.globenewswire.com/Resource/Download/7bf716f0-0fe2-4bcd-9b27-cf32ecdc577f)

Vennligst se vedlagte fil:

AGM 20200515 Nomination Committee NOR (http://ml-
eu.globenewswire.com/Resource/Download/102cd3c4-7934-4399-ae80-9adc760f6729)

For further information, contact: - For ytterligere informasjon, kontakt:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com (mailto:marianne.boe@idexbiometrics.com)
Tel: + 47 918 00186
Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
(mailto:derek.dantilio@idexbiometrics.com) Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com) and follow on Twitter @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

Mandatory notice of trade in IDEX - 14 May 2020

David Orme, senior vice president of sales and marketing of IDEX Biometrics,
purchased 3,000 shares in the market on 14 May 2020 at NOK 1.75 per share.
Following this transaction, Mr. Orme owns 203,000 shares and 2,208,600 incentive
…

Vis børsmeldingen

subscription rights in IDEX.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

Annual general meeting in IDEX Biometrics held 15 May 2020

IDEX Biometrics ASA held its annual general meeting on 15 May 2020. 214.4
million shares or 30% of the capital was represented at the meeting.

…

Vis børsmeldingen

All resolutions were made as proposed in the notice of the meeting and the
supplemental proposal.

Following the annual general meeting the board consists of chair Morten Opstad,
deputy chair Larry Ciaccia and members Deborah Davis, Hanne Høvding and Steve
Skaggs.

Following the annual general meeting the nomination committee consists of chair
Robert N. Keith and members Håvard Nilson and Harald Voigt.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

China UnionPay awards letter of approval to biometric card showcasing IDEX Biometrics technology

Oslo, Norway, 18 May 2020: IDEX Biometrics ASA, a leading provider of advanced
fingerprint identification and authentication solutions, is proud to announce
that China UnionPay has issued a Letter of Approval (LOA) for a biometric
…

Vis børsmeldingen

payment card that contains IDEX’s fingerprint sensor and distributed matcher.

The LOA is the formal acknowledgement by China UnionPay that a product or
service demonstrated compliance to all relevant requirements. This enables
world-wide interoperability with ATMs and point of sales (POS) terminal as well
as durability, reliability and security assurance.

According to China UnionPay, we always support and accept the technological
innovation of payment products and continue to pay attention to the combination
of biometric technology and payment. This is the first biometric card
certification issued by China UnionPay, which will provide more choices for
card-based payment and meet the needs of personalized and diversified payment
use case scenarios.

“The importance of certification and LOA cannot be overstated. Meeting
stringent specifications and standards to ensure global interoperability is key
in defining the growth trajectory of the biometric payment cards market,” said
Phil Sealy, Research Director, Digital Security at ABI Research. “This is a
significant market milestone, not just in terms of application security and
performance requirements, but the fact that certification and LOA must be met in
order for the biometric card to move into the mass market issuance phase”.

“CUP is the largest payment network in the world, supporting more than half of
all cards issued on the global brand networks. This LOA is a critical step to
driving mass adoption in China. IDEX and our partners are now approved for
deployment in the world’s largest market for payment cards,” said IDEX CEO,
Vince Graziani.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

IDEX Biometrics shares as board remuneration 2019-2020

The annual general meeting of IDEX Biometrics ASA on 15 May 2020 resolved that
the board members could elect to receive all or part of the board remuneration
in the form of shares in IDEX. The shares are locked up for one year from the
…

Vis børsmeldingen

date of the annual general meeting. Two board members took part of the board
remuneration in shares, and 669,055 new shares will be issued when the share
capital has been paid in.

Following the issue of the new shares to the board members, the company’s share
capital will be NOK 117,599,880.- divided into 783,999,200 registered shares
each with a nominal value of NOK 0.15.

Board member Deborah Davis will acquire 227,073 shares against payment of NOK
0.15 per share, instead of NOK 280,000 of the board remuneration. Ms Davis will
take the remainder of the board remuneration in cash. After this transaction, Ms
Davis will hold 514,479 shares and no other rights to shares in IDEX.

Board member Steve Skaggs will acquire 214,909 shares against payment of NOK
0.15 per share, instead of NOK 265,000 of the board remuneration. Mr Skaggs will
take the remainder of the board remuneration in cash. After this transaction, Mr
Skaggs will hold 664,909 shares and no other rights to shares in IDEX.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

Grant of incentive subscription rights in IDEX Biometrics 18 May 2020

The board of directors of IDEX Biometrics ASA resolved on 18 May 2020 to issue
357,300 incentive subscription rights to employees in the IDEX group. The grant
was made under the company’s 2020 incentive subscription rights plan as resolved
…

Vis børsmeldingen

at the annual general meeting on 15 May 2020. The exercise price of the
subscription rights is NOK 1.63 per share. The subscription rights vest by 25%
per year over four years and expire on 15 May 2025. Following the grant there
are 57,453,193 subscription rights outstanding in IDEX.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[Slumdog]

Noen som har noe mer info om denne avtalen? https://finansavisen.no/nyheter/teknologi/2020/05/18/7528998/idex-biometrics-fikk-godkjenning-i-kina

Hva er omfanget av den? Kan det forventes oppgang i aksjen på sikt som resultat?

[fishstick]

For min egen del, har jeg tro på at interessen for for denne type teknologi kommer til å øke betraktelig i tiden fremover. Bakgrunnen for min vurdering er at jeg tror at folk blir vesentlig mer opptatt av at dagens betalingsterminaler er potensielle smittebomber, og at det derforf vil komme krav/forventninger om bedre løsninger for å eliminere denne smitterisikoen.

Dagens situasjon viser at betalingsstedene har sett seg nødt til å innføre rutiner med jevnlig desinfeksjon av terminalene - i tillegg meldes det om en markant økning av kontaktløs betaling (tæpping), men selv denne krever jo at man i noen tilfeller må fysisk trykke på terminalene. Tenker at det er klare indikasjoner på at forbrukerne vil forvente bedre kontaktløse betalingsløsninger.

Med biometrisk verifikasjon bygd inn i kortene, unngår man fullstendig å berøre kortterminalene. I tillegg ser jeg store sikkerhetsmessige fordeler ved å unngå PIN-koder.

[TekBot]

Registration of new shares in IDEX Biometrics 19 May 2020

Reference is made to the private placement of 65.4 million shares in IDEX
Biometrics ASA on 11 May 2020.

…

Vis børsmeldingen

The capital increase has been registered and the shares will be delivered
soonest. The company’s share capital is now NOK 117,499,521.75 divided into
783,330,145 shares each with a nominal value of NOK 0.15.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief Financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[strongbuy]

Så hele state street posten på 59mill aksjer er byttet eier til Goldman Sachs siste liste. + ABG som skaper salgspress i aksjen, mon tro om de skal helt ut eller ferdigsolgte?

[TekBot]

Mandatory notice of trade in IDEX - 22 May 2020

On 22 May 2020, Vince Graziani, CEO of IDEX Biometrics, purchased 185,000 IDEX
shares in the market at USD 0.157 per share. Following this transaction, Mr.
Graziani owns 185,000 shares and 5,000,000 incentive subscription rights in
…

Vis børsmeldingen

IDEX.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[Petersen2]

Denne aksen virker å være veldig potent. Anbefaler folk å lese seg opp. Denne skal gå noen kroner på forventninger

[one]

Teknisk ser denne meget interessant ut fremover og forstår at ledelsen laster opp…

[Slumdog]

Jeg er foretatt relativt grønn I dette gamet men jeg har funnet en interesse for IDEX, her er en liten samling av de nyeste artiklene jeg har sett på om selskapet. Ingen intensjon å gjenta hva som er blitt postet tidligere, ønsker bare å dele en samling av litt av hva jeg har sett som jeg tenker kan være av interesse for flere

11.05.20
https://finansavisen.no/nyheter/teknologi/2020/05/11/7526788/idex-vurderer-rettet-emisjon-pa-opptil-100-millioner

(nevnt i tidligere post) nyheter fra 18.05.20:
https://finansavisen.no/nyheter/teknologi/2020/05/18/7528998/idex-biometrics-fikk-godkjenning-i-kina

Nyheter vedrørende betalings nettverks omfavning av biometric industrien fra 23 mai:

Biometrics embraced by major payment networks as contactless fingerprints put...

Nytt den 25.05.20:

Vince Graziani laster opp i Idex Biometrics

[TekBot]

IDEX Biometrics has received additional UK and US R&D tax relief

IDEX Biometrics has successfully claimed additional research and development tax
relief in the United Kingdom and the United States mainly related to 2019
activities, and received cash refunds of USD 650 thousand. These refunds are in
…

Vis børsmeldingen

addition to USD 850 thousand received in March of 2020 from the UK related to
2017 and 2018 research and development activities.

UK small or medium-sized enterprise R&D tax relief allows companies to deduct up
to 230% their qualifying costs from their yearly profit or claim a tax credit if
the company is loss making, worth up to 14.5% of the eligible loss. The US
allows a research and development tax credit to be applied against income taxes.
Governmental R&D support is often processed through the tax system and amounts
in excess of tax paid are reported as cost reductions under IFRS.

The company has significant research and development tax credit carryforwards in
Norway, the United Kingdom and the United States that will be applied against
taxable profits in future.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

IDEX Biometrics has received additional UK and US R&D tax relief

IDEX Biometrics has successfully claimed additional research and development tax
relief in the United Kingdom and the United States mainly related to 2019
activities, and received cash refunds of USD 650 thousand. These refunds are in
…

Vis børsmeldingen

addition to USD 850 thousand received in March of 2020 from the UK related to
2017 and 2018 research and development activities.

UK small or medium-sized enterprise R&D tax relief allows companies to deduct up
to 230% their qualifying costs from their yearly profit or claim a tax credit if
the company is loss making, worth up to 14.5% of the eligible loss. The US
allows a research and development tax credit to be applied against income taxes.
Governmental R&D support is often processed through the tax system and amounts
in excess of tax paid are reported as cost reductions under IFRS.

The company has significant research and development tax credit carryforwards in
Norway, the United Kingdom and the United States that will be applied against
taxable profits in future.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 197 827 31344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[one]

Cashless after COVID-19: why touch-free transactions could see us finally say...